ArticleOncology2026

Lymphatic Metastasis Predicts Better Response to Nivolumab in Recurrent or Metastatic Gastric Cancer: Insights from Tumor-Draining Lymph Node Immunity and Long-Term Outcomes.

Shuichiro Oya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.